Cargando…
New oral spherical carbon adsorbent effectively reduces serum indoxyl sulfate levels in moderate to advanced chronic kidney disease patients: a multicenter, prospective, open-label study
BACKGROUND: Elevated levels of serum indoxyl sulfate (IS) have been linked to cardiovascular complications in patients with chronic kidney disease (CKD). Oral sorbent therapy using spherical carbons selectively attenuates IS accumulation in CKD patients. This study aimed to investigate whether oral...
Autores principales: | Kim, Seok-hyung, Jhee, Jong Hyun, Choi, Hoon Young, Lee, Sang-Ho, Shin, Sug Kyun, Lee, So-Young, Yang, Dong Ho, Yi, Joo-Hark, Han, Sang-Woong, Jo, Young-Il, Park, Hyeong Cheon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394678/ https://www.ncbi.nlm.nih.gov/pubmed/32736531 http://dx.doi.org/10.1186/s12882-020-01971-x |
Ejemplares similares
-
Indoxyl sulfate promotes apoptosis in cultured osteoblast cells
por: Kim, Young-Hee, et al.
Publicado: (2013) -
Effect of low-dose valsartan on proteinuria in normotensive immunoglobulin A nephropathy with minimal proteinuria: a randomized trial
por: Jo, Young-Il, et al.
Publicado: (2016) -
Moderate Increase of Indoxyl Sulfate Promotes Monocyte Transition into Profibrotic Macrophages
por: Barisione, Chiara, et al.
Publicado: (2016) -
Indoxyl sulfate impairs valsartan-induced neovascularization()
por: Kuo, Ko-Lin, et al.
Publicado: (2020) -
Indoxyl Sulfate, a Uremic Endotheliotoxin
por: Lano, Guillaume, et al.
Publicado: (2020)